Literature DB >> 18363675

Fine deletion analysis of 1p36 chromosomal region in oral squamous cell carcinomas.

Mathieu Lefeuvre1, Mehmet Gunduz, Hitoshi Nagatsuka, Esra Gunduz, Mahmoud Al Sheikh Ali, Levent Beder, Kunihiro Fukushima, Noboru Yamanaka, Kenji Shimizu, Noriyuki Nagai.   

Abstract

BACKGROUND: Squamous cell carcinoma is the most common cancer type of the oral cavity and approximately 50% of the patients succumb to the disease. Unfortunately, few are known about the molecular mechanisms involving in the formation of oral squamous cell carcinoma (OSCC). Recently, it has been reported that 1p36 chromosomal region is deleted in various cancer types and is suspected to harbor various tumor suppressor genes (TSGs). However, limited studies exist on genetics alteration on 1p36 in OSCC and the responsible TSG remained unidentified.
METHODS: To investigate area susceptible to harbor TSG(s) involved in OSCC on 1p36 region, paired normal and tumor tissues of 27 patients with diagnosis of OSCC have been analyzed for loss of heterozygosity (LOH) using nine microsatellite markers based on recent gene mapping.
RESULTS: LOH was found at least in one locus in 85% of the cases (23 of 27). Interestingly, microsatellite instability was also found in 7% (two of 27) of the cases analyzed. The higher LOH frequencies were found with the markers D1S243 (25%), D1S468 (22%), D1S450 (25%), D1S228 (38%), D1S199 (28%), and D1S1676 (23%).
CONCLUSIONS: Three preferentially deleted regions have been identified in OSCC: region 1 (D1S468-D1S243), region 2 (D1S450-D1S228), and region 3 (D1S199-D1S1676). Multiple candidate TSGs, such as RIZ1, p73, UBE4B, Rap1GAP, EPHB2, and RUNX3, are located in these three areas. The data obtained in this study can be used for further functional analysis of these genes involved in OSCC carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18363675     DOI: 10.1111/j.1600-0714.2008.00666.x

Source DB:  PubMed          Journal:  J Oral Pathol Med        ISSN: 0904-2512            Impact factor:   4.253


  8 in total

1.  Reduced expression of EphB2 is significantly associated with nodal metastasis in Chinese patients with gastric cancer.

Authors:  Guanzhen Yu; Yunshu Gao; Canrong Ni; Ying Chen; Jun Pan; Xi Wang; Zhiwei Ding; Jiejun Wang
Journal:  J Cancer Res Clin Oncol       Date:  2010-03-18       Impact factor: 4.553

2.  Identification of copy number alterations by array comparative genomic hybridization in patients with late chronic or accelerated phase chronic myeloid leukemia treated with imatinib mesylate.

Authors:  Veera S Nadarajan; Chin-Lee Phan; Chow-Hiang Ang; Kai-Ling Liang; Gin-Gin Gan; Ping-Chong Bee; Zubaidah Zakaria
Journal:  Int J Hematol       Date:  2011-03-09       Impact factor: 2.490

3.  Prognostic significance of 1p36 locus deletion in adenoid cystic carcinoma of the salivary glands.

Authors:  Petr Šteiner; Simon Andreasen; Petr Grossmann; Lukáš Hauer; Tomáš Vaněček; Markéta Miesbauerová; Thalita Santana; Katalin Kiss; David Slouka; Alena Skálová
Journal:  Virchows Arch       Date:  2018-04-04       Impact factor: 4.064

4.  E2F2 suppresses Myc-induced proliferation and tumorigenesis.

Authors:  Raju V Pusapati; Regina L Weaks; Robert J Rounbehler; Mark J McArthur; David G Johnson
Journal:  Mol Carcinog       Date:  2010-02       Impact factor: 4.784

5.  Inactivation of RUNX3 protein expression in tongue squamous cell carcinoma and its association with clinicopathological characteristics.

Authors:  Wei-Na Zhou; Yi-Fei Du; Yang Zheng; Wei Zhang; Yu-Nong Wu; Xiao-Meng Song; Jin Bai
Journal:  Mol Med Rep       Date:  2018-11-29       Impact factor: 2.952

Review 6.  The Role of E3, E4 Ubiquitin Ligase (UBE4B) in Human Pathologies.

Authors:  Nikolaos Antoniou; Nefeli Lagopati; Dimitrios Ilias Balourdas; Michail Nikolaou; Alexandros Papalampros; Panagiotis V S Vasileiou; Vassilios Myrianthopoulos; Athanassios Kotsinas; Yosef Shiloh; Michalis Liontos; Vassilis G Gorgoulis
Journal:  Cancers (Basel)       Date:  2019-12-24       Impact factor: 6.639

7.  The Roles of Ubiquitination Factor E4B (UBE4B) in the Postoperative Prognosis of Patients with Renal Cell Carcinoma and in Renal Tumor Cells Growth and Metastasis.

Authors:  Xu-Qiong Huang; Shuai Hao; Zi-Qi Zhou; Bin Huang; Jia-Ying Fang; Yan Tang; Jian-Hua Zhang; Jian-Chuan Xia
Journal:  Onco Targets Ther       Date:  2020-01-08       Impact factor: 4.147

Review 8.  The Roles of EphB2 in Cancer.

Authors:  Wei Liu; Chengpeng Yu; Jianfeng Li; Jiwei Fang
Journal:  Front Cell Dev Biol       Date:  2022-02-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.